Oldelft Ultrasound Receives Majority Investment from Gimv

Oldelft Ultrasound, a Delft, The Netherlands-based medical diagnostic company, has received a a majority investment from Gimv.

The amount of the transaction remained undisclosed.

Gimv, which invested alongside the existing management team of the company, has acquired its stake from AlpInvest. It intends to support Oldelft’s plans for further innovation and international growth.

Led by CEO Rob Smallenburg, Oldelft Ultrasound is specialized in the miniaturization of transducers, mostly to diagnose cardiovascular disorders, and is especially known for its TEE (Trans Esophageal Echocardiography) transducers. A formerly subsidiary of Delft Instruments, the company serves global OEMs, which supply ultrasound systems to hospitals and other medical institutions. It currently employs about 50 people and collaborates with different technical and medical universities (e.g. Delft and Rotterdam).



Join the discussion